Hubei Jumpcan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hubei Jumpcan Pharmaceutical has a total shareholder equity of CN¥14.1B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 8.7%. Its total assets and total liabilities are CN¥18.2B and CN¥4.1B respectively. Hubei Jumpcan Pharmaceutical's EBIT is CN¥2.7B making its interest coverage ratio -8.2. It has cash and short-term investments of CN¥11.7B.
Key information
8.7%
Debt to equity ratio
CN¥1.22b
Debt
| Interest coverage ratio | -8.2x |
| Cash | CN¥11.70b |
| Equity | CN¥14.10b |
| Total liabilities | CN¥4.06b |
| Total assets | CN¥18.15b |
Recent financial health updates
Recent updates
Why Investors Shouldn't Be Surprised By Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) 26% Share Price Plunge
Sep 11
An Intrinsic Calculation For Hubei Jumpcan Pharmaceutical Co., Ltd. (SHSE:600566) Suggests It's 45% Undervalued
Sep 09Is Hubei Jumpcan Pharmaceutical (SHSE:600566) A Risky Investment?
Aug 07Is Now The Time To Put Hubei Jumpcan Pharmaceutical (SHSE:600566) On Your Watchlist?
Jul 01Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Prospects Need A Boost To Lift Shares
May 30Hubei Jumpcan Pharmaceutical (SHSE:600566) Ticks All The Boxes When It Comes To Earnings Growth
Mar 17Financial Position Analysis
Short Term Liabilities: 600566's short term assets (CN¥14.3B) exceed its short term liabilities (CN¥3.9B).
Long Term Liabilities: 600566's short term assets (CN¥14.3B) exceed its long term liabilities (CN¥202.8M).
Debt to Equity History and Analysis
Debt Level: 600566 has more cash than its total debt.
Reducing Debt: 600566's debt to equity ratio has reduced from 9.8% to 8.7% over the past 5 years.
Debt Coverage: 600566's debt is well covered by operating cash flow (191.4%).
Interest Coverage: 600566 earns more interest than it pays, so coverage of interest payments is not a concern.